Consequences of the Evolution of the GABAA Receptor Gene Family
- 1 June 2005
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 25 (3-4) , 607-624
- https://doi.org/10.1007/s10571-005-4004-4
Abstract
1. This paper reviews the evolution of the family of genes present in mammals and other vertebrates that encode γ-aminobutyric acid (GABA) type A (GABAA) receptors, which are the major inhibitory neurotransmitter receptors in the central nervous system (CNS). In mammals, 16 different polypeptides (α1–α6, β1–β3, γ1–γ3, δ, ε, π, and θ) have been identified, using recombinant DNA techniques, each of which is encoded by a distinct gene. The products of these genes assemble in diverse combinations to form a variety of receptor subtypes that have different sensitivities to a number of clinically relevant compounds, such as the benzodiazepines (BZs). 2. Based on a number of chromosomal mapping techniques, the majority of the GABAA receptor genes have been localized, in man, in four clusters on chromosomes 4, 5, 15, and the X. Furthermore, the genes that are present within these clusters have a conserved transcriptional orientation. It has, therefore, been proposed that the clusters arose largely as a consequence of two whole-genome doublings that occurred during chordate evolution, and that the ancestral cluster contained an “α-like,” a “β-like,” and a “γ-like” subunit gene. 3. Our laboratory has identified two additional GABAA receptor polypeptides (the β4 and γ4 subunits) in a number of vertebrate species; these do not appear to be present in mammals. We discuss here the relationship of the corresponding genes to other GABAA receptor genes, and conclude that their products are orthologous to the mammalian θ and ε subunits, respectively. 4. The GABAA receptor has a number of binding sites for compounds such as BZs, barbiturates, neurosteroids, and certain volatile anaesthetics. However, the only site at which endogenous compounds are thought to be active is the steroid site; this binds steroids such as certain metabolites of progesterone and deoxycorticosterone, which are synthesized in the periphery and CNS. Since the in vivo functional relevance, if any, of binding sites for other classes of compounds (such as the BZs) is unknown, the significance of differences in primary sequence, between different receptor subunits, is uncertain. We suggest that a possibly more important consequence of gene duplication is that it permitted greater flexibility in the level, pattern and regulation of expression of GABAA receptor genes.Keywords
This publication has 106 references indexed in Scilit:
- Forced Subunit Assembly in α1β2γ2 GABAAReceptorsJournal of Biological Chemistry, 2002
- Unraveling the function of GABAA receptor subtypesTrends in Pharmacological Sciences, 2000
- Evolution of GABAA receptor diversity in the human genomeGene, 1999
- Eukaryote genome duplication - where's the evidence?Current Opinion in Genetics & Development, 1998
- A Gene in Human Chromosome Band Xq28 (GABRE) Defines a Putative New Subunit Class of the GABAANeurotransmitter ReceptorGenomics, 1997
- Mapping of the β2 Subunit Gene (GABRB2) to Microdissected Human Chromosome 5q34-q35 Defines a Gene Cluster for the Most Abundant GABAA Receptor IsoformGenomics, 1994
- The Human γ-Aminobutyric Acid Receptor Subunit β3 and α5 Gene Cluster in Chromosome 15q11-q13 Is Rich in Highly Polymorphic (CA)n RepeatsGenomics, 1994
- Stoichiometry of a recombinant GABAA receptor deduced from mutation-induced rectificationNeuroReport, 1993
- The rapid generation of mutation data matrices from protein sequencesBioinformatics, 1992
- Conserved Organization of ?-Aminobutyric AcidAReceptor Genes: Cloning and Analysis of the Chicken ?4-Subunit GeneJournal of Neurochemistry, 1991